Christian Récher, Marie-Anne Hospital, Thibaut Leguay, Martin Carré, Corentin Orvain, Caroline Bonmati, Emmanuel Raffoux, Célestine Simand, Romain Guieze, Jamilé Frayfer, Juliette Lambert, Sylvain Chantepie, Marc Bernard, Pierre Peterlin, Magda Alexis, Pascal Turlure, Cécile Pautas, Sarah Bertoli, Ludovic Gabellier, Edouard Forcade, Nicolas Duployez, Isabelle Luquet, Dominique Penther, Karine Celli-Lebras, Ariane Mineur, Claude Gardin, Norbert Ifrah, Norbert Vey, Régis Peffault de Latour, Pierre-Yves Dumas, Éric Delabesse, Claude Preudhomme, Jean-François Hamel, Hervé Dombret, Arnaud Pigneux, Hunault-Berger Mathilde, Stéphane de Botton. "Randomized study of high-dose cytarabine with or without dexamethasone as post-remission therapy in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups." Blood, 2025. doi:10.1182/blood-2025-881